Movatterモバイル変換

[0]ホーム
URL:

ATE216221T1 - SODIUM HYALURONATE-BASED OPHTHALMIC FORMULATION FOR USE IN EYE SURGERY - Google Patents

SODIUM HYALURONATE-BASED OPHTHALMIC FORMULATION FOR USE IN EYE SURGERY

Info

Publication number
ATE216221T1
ATE216221T1AT96120457TAT96120457TATE216221T1AT E216221 T1ATE216221 T1AT E216221T1AT 96120457 TAT96120457 TAT 96120457TAT 96120457 TAT96120457 TAT 96120457TAT E216221 T1ATE216221 T1AT E216221T1
Authority
AT
Austria
Prior art keywords
sodium hyaluronate
eye surgery
ophthalmic formulation
based ophthalmic
formulation
Prior art date
Application number
AT96120457T
Other languages
German (de)
Inventor
Rene-Pierre Buenter
Original Assignee
Chemedica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemedica SafiledCriticalChemedica Sa
Application grantedgrantedCritical
Publication of ATE216221T1publicationCriticalpatent/ATE216221T1/en

Links

Classifications

Landscapes

Abstract

The present invention relates to an ophthalmic formulation, for use in eye surgery, comprising sodium hyaluronate, citrate, at least one antioxidant tolerated by the intraocular tissues and a phosphate buffer.
AT96120457T1995-12-221996-12-19 SODIUM HYALURONATE-BASED OPHTHALMIC FORMULATION FOR USE IN EYE SURGERYATE216221T1 (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
IT95MI002744AIT1277707B1 (en)1995-12-221995-12-22 OPHTHALMIC FORMULATION BASED ON SODIUM HYALURONATE FOR USE IN OCULAR SURGERY

Publications (1)

Publication NumberPublication Date
ATE216221T1true ATE216221T1 (en)2002-05-15

Family

ID=11372809

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AT96120457TATE216221T1 (en)1995-12-221996-12-19 SODIUM HYALURONATE-BASED OPHTHALMIC FORMULATION FOR USE IN EYE SURGERY

Country Status (10)

CountryLink
US (1)US5880107A (en)
EP (1)EP0781547B1 (en)
JP (1)JP4146910B2 (en)
AT (1)ATE216221T1 (en)
CA (1)CA2193543C (en)
DE (1)DE69620724T2 (en)
DK (1)DK0781547T3 (en)
ES (1)ES2175020T3 (en)
IT (1)IT1277707B1 (en)
PT (1)PT781547E (en)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6541460B2 (en)1996-08-072003-04-01George D. PetitoMethod for use of hyaluronic acid in wound management
US6368585B1 (en)*1997-03-252002-04-09Pharmacia AbOpthalmic compositions and methods
US20030138499A1 (en)*1998-12-172003-07-24Shah Mandar V.Stable surgical irrigating solutions
US6533769B2 (en)*2001-05-032003-03-18Holmen JoergenMethod for use in cataract surgery
US7820194B2 (en)2001-12-212010-10-26Alcon, Inc.Combinations of viscoelastics for use during surgery
ITMI20020557A1 (en)*2002-03-152003-09-15Acraf USE OF A SALT OF L-ASCORBIC ACID TO PREPARE A PHARMACEUTICAL COMPOSITION FOR TOPICAL OPHTHALMIC USE CAPABLE OF IMPROVING THE LEVEL D
US20040167480A1 (en)*2003-02-212004-08-26Advanced Medical Optics, Inc.Administration of multiple viscoelastic solutions with a multi-compartment syringe
FR2861734B1 (en)2003-04-102006-04-14Corneal Ind CROSSLINKING OF LOW AND HIGH MOLECULAR MASS POLYSACCHARIDES; PREPARATION OF INJECTABLE SINGLE PHASE HYDROGELS; POLYSACCHARIDES AND HYDROGELS OBTAINED
US20050215516A1 (en)*2004-03-292005-09-29Claudio BucoloNew free-radical scavenger containing viscoelastic composition, methods of use and package
US20060073184A1 (en)*2004-09-292006-04-06Bausch & Lomb Inc.Viscoelastic composition, methods of use and packaging device with anti-oxidant
WO2008042441A1 (en)*2006-10-032008-04-10Anthrogenesis CorporationUse of umbilical cord biomaterial for ocular surgery
AU2008256819A1 (en)*2007-05-232008-12-04Allergan, Inc.Cross-linked collagen and uses thereof
US8318695B2 (en)*2007-07-302012-11-27Allergan, Inc.Tunably crosslinked polysaccharide compositions
US8697044B2 (en)2007-10-092014-04-15Allergan, Inc.Crossed-linked hyaluronic acid and collagen and uses thereof
EP3498299A1 (en)2007-11-162019-06-19Aclaris Therapeutics, Inc.Compositions and methods for treating purpura
US20090143348A1 (en)*2007-11-302009-06-04Ahmet TezelPolysaccharide gel compositions and methods for sustained delivery of drugs
US8394782B2 (en)*2007-11-302013-03-12Allergan, Inc.Polysaccharide gel formulation having increased longevity
US8394784B2 (en)*2007-11-302013-03-12Allergan, Inc.Polysaccharide gel formulation having multi-stage bioactive agent delivery
EP2229180A1 (en)*2007-12-272010-09-22D.M.G. Italia SrlComposition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan
US8357795B2 (en)*2008-08-042013-01-22Allergan, Inc.Hyaluronic acid-based gels including lidocaine
ES2829971T3 (en)2008-09-022021-06-02Tautona Group Lp Hyaluronic acid threads and / or derivatives thereof, methods to manufacture them and uses thereof
US20100104654A1 (en)*2008-10-272010-04-29Allergan, Inc.Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
JP4885245B2 (en)*2009-01-152012-02-29日本航空電子工業株式会社 RD converter and angle detection device
JP2013513622A (en)*2009-12-142013-04-22ユニバーシティ オブ マサチューセッツ Methods for inhibiting cataracts and presbyopia
US20110172180A1 (en)2010-01-132011-07-14Allergan Industrie. SasHeat stable hyaluronic acid compositions for dermatological use
US20110171311A1 (en)*2010-01-132011-07-14Allergan Industrie, SasStable hydrogel compositions including additives
US9114188B2 (en)2010-01-132015-08-25Allergan, Industrie, S.A.S.Stable hydrogel compositions including additives
US20110171310A1 (en)*2010-01-132011-07-14Allergan Industrie, SasHydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
EP2544652A2 (en)2010-03-122013-01-16Allergan Industrie SASA fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition.
PL2550027T5 (en)2010-03-222019-07-31Allergan, Inc.Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US8697057B2 (en)2010-08-192014-04-15Allergan, Inc.Compositions and soft tissue replacement methods
US8889123B2 (en)2010-08-192014-11-18Allergan, Inc.Compositions and soft tissue replacement methods
US9005605B2 (en)2010-08-192015-04-14Allergan, Inc.Compositions and soft tissue replacement methods
US8883139B2 (en)2010-08-192014-11-11Allergan Inc.Compositions and soft tissue replacement methods
US9408797B2 (en)2011-06-032016-08-09Allergan, Inc.Dermal filler compositions for fine line treatment
KR102154944B1 (en)2011-06-032020-09-11알러간 인더스트리 에스에이에스Dermal filler compositions including antioxidants
US9393263B2 (en)2011-06-032016-07-19Allergan, Inc.Dermal filler compositions including antioxidants
US20130096081A1 (en)2011-06-032013-04-18Allergan, Inc.Dermal filler compositions
US9662422B2 (en)2011-09-062017-05-30Allergan, Inc.Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en)2011-09-062013-09-19Allergan, Inc.Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US11058677B2 (en)*2012-12-192021-07-13Novartis AgLFA-1 inhibitor formulations
AT514540A1 (en)*2013-06-182015-01-15Apomedica Pharmazeutische Produkte Gmbh Ophthalmic composition
EP4137139A1 (en)2013-07-102023-02-22Matrix Biology InstituteCompositions of hyaluronan with high elasticity and uses thereof
JPWO2015125921A1 (en)*2014-02-202017-03-30わかもと製薬株式会社 Pharmaceutical aqueous composition having storage efficacy
EP3620184A1 (en)2014-09-302020-03-11Allergan Industrie, SASStable hydrogel compositions including additives
WO2016128783A1 (en)2015-02-092016-08-18Allergan Industrie SasCompositions and methods for improving skin appearance
AU2016217792B2 (en)2015-02-132020-07-02Allergan Industrie, SasImplants for sculpting, augmenting or correcting facial features such as the chin
WO2017031312A1 (en)*2015-08-182017-02-23Astellas Institute For Regenerative MedicineClinical formulations
US10383889B2 (en)2015-09-242019-08-20Matrix Biology InstituteHigh elasticity hyaluronan compositions and methods of use thereof
EP3525799B1 (en)*2016-10-142022-01-26i.com Medical GmbHMethod for establishing, restoring, and preserving homeostasis of the ocular surface
EP3713617A1 (en)*2017-11-222020-09-30Bausch & Lomb IncorporatedOphthalmic viscoelastic compositions
CN113354757B (en)*2021-06-262022-04-08上海加新生物科技有限公司Preparation method of small molecule sodium hyaluronate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4141973A (en)1975-10-171979-02-27Biotrics, Inc.Ultrapure hyaluronic acid and the use thereof
US5409904A (en)*1984-11-131995-04-25Alcon Laboratories, Inc.Hyaluronic acid compositions and methods
US4886786A (en)*1985-08-011989-12-12Lindstrom Richard LAdditive for irrigation solution or surgical solution
IL80298A (en)1986-10-141993-01-31Res & Dev Co LtdEye drops
US4920104A (en)*1988-05-161990-04-24Medchem Products, Inc.Sodium hyaluronate composition
DK0464727T3 (en)*1990-06-291996-02-05Santen Pharmaceutical Co Ltd Use of a composition for the manufacture of a drug for debridement of retained lens materials
WO1994007505A1 (en)*1991-07-031994-04-14Norpharmco Inc.Use of hyaluronic acid and forms to prevent arterial restenosis
JPH06107538A (en)*1992-03-311994-04-19Shiseido Co LtdBulb of eye preserving solution for cornea graft
JPH05310580A (en)*1992-04-301993-11-22Shiseido Co LtdLiquid preparation for entopic perfusion

Also Published As

Publication numberPublication date
ITMI952744A1 (en)1997-06-22
EP0781547B1 (en)2002-04-17
JPH09216826A (en)1997-08-19
ES2175020T3 (en)2002-11-16
PT781547E (en)2002-09-30
DE69620724T2 (en)2002-11-21
ITMI952744A0 (en)1995-12-22
IT1277707B1 (en)1997-11-11
EP0781547A1 (en)1997-07-02
DK0781547T3 (en)2002-08-12
JP4146910B2 (en)2008-09-10
DE69620724D1 (en)2002-05-23
US5880107A (en)1999-03-09
CA2193543A1 (en)1997-06-23
CA2193543C (en)2006-02-21

Similar Documents

PublicationPublication DateTitle
DE69620724D1 (en) Sodium hyaluronate-based ophthalmic formulation for use in eye surgery
DE69420196D1 (en) Ophthalmic device for the anterior eye area
ATE202706T1 (en) USE OF 9-DEOXYPROSTAGLAND INDERIVATIVES FOR THE TREATMENT OF GLAUCOMA
BR9808282A (en) Controlled release of pharmaceuticals into the anterior chamber of the eye
SE8403090D0 (en) GEL FOR USE AS A GLASS BODY SUBSTITUTE
NO891909D0 (en) REPLACEMENT CORRECTION IMPLANT IN AN EYE'S ROOM.
ZA957633B (en)Corneal template and surgical procedure for refractive vision correction.
IE893270L (en)Ophthalmic staple and instruments for implementing use
LV10688A (en) Anti-allergic composition for ophthalmology or nasal disease
DE69718633D1 (en) Microkeratome for corneal surgery using laser
FI970489A7 (en) Topical ophthalmic compositions containing doxepin derivatives and suitable for the treatment of allergic eye diseases
AU4128901A (en)Colored visco-elastic composition
DE69943067D1 (en) Use of three-dimensional prostheses containing hyaluronic acid derivatives
AU5446299A (en)Medicinal compositions for treating eye diseases
ES2052893T3 (en) N-ACETYL-GLUCOSAMINE PREPARATION FOR ADMINISTRATION BY ROUTE.
CA2282757A1 (en)Opthalmic composition
ATE114470T1 (en) TREATMENT OF INTRAOCULAR PRESSURE WITH A SYNERGISTIC COMBINATION FOR OPHTHALMIC USE.
FR2670670B1 (en) CORNEAL SURGERY INSTRUMENT.
ES2069823T3 (en) TREATMENT OF EYE HYPERTENSION WITH AN EYE SYNERGIC COMBINATION.
DE69100171D1 (en) SYNERGISTIC COMBINATION FOR OPHTHALMIC USE.
WO2002036096A8 (en)Non-aspirating transitional viscoelastics for use in surgery
ATE202922T1 (en) OPHTHALMIC CROMOLYNE GEL PREPARATION
DE69914066D1 (en) eyewash
ATE158719T1 (en) USE OF HEXETIDINE OR DERIVATIVES OR SALTS THEREOF FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC USE
RU97113443A (en) METHOD FOR TREATING EYE BURNS

Legal Events

DateCodeTitleDescription
UEPPublication of translation of european patent specification
[8]ページ先頭
©2009-2025 Movatter.jp